URAPIDIL STRAGEN 25 mg/5 ml, solution for injection 5 ampoules of 5 ml
Active ingredients: Urapidil
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- URAPIDIL STRAGEN 25 mg/5 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoules en verre de 5 mL
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66112441CIP73013295CIP133400930132951Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| URAPIDILsolution | 25 mg · une ampoule de 5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.